Hepatoma-derived growth factor expression as a prognostic marker in cervical cancer

doi:10.5317/wjog.v4.i1.16

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5339)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

353

WORD

281

HTML

2041

Figures (1-2)

218

Tables (1-3)

235

Sum=3128

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1081

Download

1130

Sum=2211

Feb 10, 2015 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Obstetrics and Gynecology

ISSN

2218-6220

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Obstet Gynecol. Feb 10, 2015; 4(1): 16-23
Published online Feb 10, 2015. doi: 10.5317/wjog.v4.i1.16

Table 3 Multivariate analysis of overall survival with clinicopathological factors in uterine cervical cancer patients

Factor	Category	χ²value	P value
Histological differentiation	1: Keratinized and nonkeratinized squamous cell carcinoma	0.51	0.474
Histological differentiation	0: Adenosquamous carcinoma
Vascular permeation	1: Absent	0.16	0.686
Vascular permeation	0: Present
Depth of invasion (pT)-A	1: T1	1.19	0.275
Depth of invasion (pT)-A	0: T2-4
Depth of invasion (pT)-B	1: T1 and 2	3.06	0.0801
Depth of invasion (pT)-B	0: T3 and 4
Lymph node metastasis (pN)	1: Absent	5.43	0.0197
Lymph node metastasis (pN)	0: Present
Hepatoma-derived growth factor expression	1: Level 0 and 1	5.94	0.0148
Hepatoma-derived growth factor expression	0: Level 2

Citation: Song M, Tomoeda M, Jin YF, Kubo C, Yoshizawa H, Kitamura M, Nagata S, Ohta Y, Kamiura S, Nakamura H, Tomita Y. Hepatoma-derived growth factor expression as a prognostic marker in cervical cancer. World J Obstet Gynecol 2015; 4(1): 16-23
URL: https://www.wjgnet.com/2218-6220/full/v4/i1/16.htm
DOI: https://dx.doi.org/10.5317/wjog.v4.i1.16